Suppliers / Shanghai Ziyuan Pharmaceutical

Shanghai Ziyuan Pharmaceutical

China Updated 9 July 2026

Shanghai Ziyuan Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Fosphenytoin US FDA 1
Naftifine US FDA 1

Also appears on these molecule pages

Naftifine API

Questions about Shanghai Ziyuan Pharmaceutical

Does Shanghai Ziyuan Pharmaceutical hold a US DMF or a CEP?
Shanghai Ziyuan Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Shanghai Ziyuan Pharmaceutical make?
2 molecules are on record against Shanghai Ziyuan Pharmaceutical, including Fosphenytoin and Naftifine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shanghai Ziyuan Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 1 molecule Olon shares 1 molecule Erregierre shares 1 molecule Chongqing Huapont Pharmaceutical shares 1 molecule Novartis shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability